Skip to main content
In stock|Targeted Therapy (Investigational)

Zoldonrasib

Oncology TypeSolid Tumour
Drug Class / MechanismRAS(ON) G12D-Selective Tri-Complex Inhibitor
No Image
Description

Zoldonrasib is classified as a RAS(ON) G12D-Selective Tri-Complex Inhibitor, sourced for use within our Targeted Therapy (Investigational) portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic CategoryTargeted Therapy (Investigational)
Oncology TypeSolid Tumour

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3